Reaction

Oral Pruritus reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,262 reports · 39 co-occurring drugs

As of the last recalculation, Oral Pruritus appears in 2,262 FAERS reports alongside 39 co-occurring drug terms. The strongest observed disproportionality signal is DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED (PRR 32.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Diphenhydramine Hydrochloride Capsule, Liquid Filled	74	32.9	33.0
Iohexol	20	22.4	22.4
Rizatriptan Benzoate	16	14.6	14.6
Ciclesonide	21	14.3	14.3
Cetirizine Hydrochloride Allergy	41	12.7	12.7
Cetirizine Hydrochloride Tablets	41	12.7	12.7
Diphenhydramine Hydrochloride	200	12.1	12.1
Methylprednisolone Sodium Succinate	56	11.4	11.4
Methylprednisolone	147	10.4	10.4
Desloratadine	12	10.3	10.4
Eptinezumab-Jjmr	10	10.2	10.2
Fexofenadine	18	10.1	10.1
Omalizumab	85	9.5	9.5
Polatuzumab Vedotin	10	9.5	9.5
Cetirizine	76	9.3	9.3
Diphenhydramine	55	8.2	8.2
Cetirizine Hydrochloride	137	8.1	8.1
Ceftriaxone Sodium	32	7.8	7.8
Ocrelizumab	50	7.6	7.6
Cetiirizine	33	7.3	7.3
Adrenalinum	32	7.2	7.2
Rituximab	154	7.1	7.1
Ceftriaxone	25	7.1	7.1
Epinephrine	48	6.9	6.9
Fexofenadine Hydrochloride	12	5.1	5.1
Alpelisib	4	4.2	4.2
Nicotine Polacrilex	17	4.1	4.1
Asfotase Alfa	4	3.7	3.7
Mometasone Furoate And Formoterol Fumarate Dihydrate	6	3.5	3.5
Vibegron	3	3.4	3.4
Daratumumab	14	3.2	3.2
Benralizumab	7	3.2	3.2
Rimegepant Sulfate	4	2.9	2.9
Emtricitabine And Tenofovir Alafenamide	3	2.4	2.4
Nirmatrelvir And Ritonavir	12	2.0	2.0
Glycerin, Lidocaine	3	2.0	2.0
Docosanol	3	1.9	1.9
Galcanezumab-Gnlm	4	1.2	1.2
Dupilumab	58	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.